PolarityTE Inc

NASDAQ:PTE   3:58:00 PM EDT
0.70
-0.02 (-2.26%)
Regulatory, Earnings Announcements

Polarityte Reports Second Quarter Financial Results And Provides Business Update

Published: 08/12/2021 20:09 GMT
PolarityTE Inc (PTE) - Polarityte Reports Second Quarter Financial Results and Provides Business Update.
Q2 Revenue $2.54 Million.
Q2 Revenue Estimate $3.2 Million -- Refinitiv Ibes Data (analyst estimates).
Reported Skinte Met Primary and Secondary Endpoints in Final Analysis From Diabetic Foot Ulcer (dfu) Trial.
Ceased Commercial Sales of Skinte on May 31, and Has Made Substantial Reductions in Costs Associated With Its Commercial Operations.
On July 23, 2021 Company Submitted to FDA an Ind for Skinte for Treatment of Chronic Cutaneous Ulcers.
Qtrly Loss per Share $0.06.
Revenue is expected to be $0.81 Million
Adjusted EPS is expected to be -$0.12

Next Quarter Revenue Guidance is expected to be $0.73 Million
Next Quarter EPS Guidance is expected to be -$0.12

More details on our Analysts Page.